Nigeria’s public health infrastructure has received a significant enhancement with the official commissioning of a state-of-the-art Tuberculosis (TB) Modular Laboratory at the Defense Reference Laboratory in Mogadishu Cantonment, Abuja.
The facility, inaugurated on August 20, 2024, marks a milestone in the fight against TB in Nigeria and strengthens the ongoing health collaboration between Nigeria and the United States. According to a statement from the U.S. Embassy, the laboratory was fully certified in June 2024 by the Walter Reed Army Institute of Research, and it will play a critical role in bolstering the capabilities of Nigeria’s National TB and Leprosy Programme.
The commissioning ceremony was led by Dr. Bello Mutawalle, Nigeria’s Minister of State for Defense, and attended by key figures including U.S. Ambassador to Nigeria Richard Mills, Colonel Eli Lozano, Commander of the Walter Reed Army Institute of Research (WRAIR), and Brig. Gen. NAE Okeji (Rtd), Director General of the Nigerian Ministry of Defence Health Implementation Programme, alongside other prominent health and defense leaders.
Equipped with advanced molecular diagnostic tools, including line probe assays and Drug Sensitivity Testing (DST), the laboratory is designed to detect drug-resistant TB strains. It will expand TB case detection and integrate HIV and TB diagnostic services, significantly improving access to life-saving diagnostics for both military personnel and civilian populations.
This development is the latest achievement in the long-standing partnership between the Nigerian Ministry of Defense Health Implementation Programme (MODHIP) and WRAIR Africa. Established 19 years ago, the collaboration initially focused on HIV prevention, care, and treatment for military personnel and their families. Over time, it has expanded to address TB, malaria, clinical research, and vaccine trials, tackling both emerging and re-emerging infectious diseases in Nigeria.
U.S. Ambassador Richard Mills highlighted the importance of the partnership, stating, “The U.S. government’s investment in the health of Nigerians reflects Nigeria’s pivotal role on the continent. Our substantial investment, made possible by the generosity of the American people, enables us to provide crucial funding and technical assistance across a range of health priorities.”
The TB Modular Laboratory stands as a testament to the enduring strength of the U.S.-Nigeria partnership. This collaboration has been instrumental in elevating the standard of medical services in military health facilities across Nigeria. With the integration of cutting-edge technology and rigorous research, the MODHIP-WRAIR Africa partnership continues to advance Nigeria’s capacity to combat infectious diseases and improve public health outcomes.
As Nigeria continues to face challenges in combating TB and other infectious diseases, the new laboratory is poised to play a crucial role in ensuring accurate diagnoses and saving lives. It will also support Nigeria’s broader efforts in the global fight against drug-resistant TB strains.
Helina Meri, Country Director of WRAIR Africa in Nigeria, expressed gratitude to all collaborators involved in the establishment of the laboratory, stating, “The greatest joy will be to see this laboratory put to full use in combating TB, ensuring that both military and civilian populations benefit from the highest standards of care in Nigeria.”
